Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 19 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 8536195

    Bicyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted
  2. US 8529882

    Peptidomimetic protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  3. US 8530489

    5-cyano-4-(pyrrolo [2,3B] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  4. US 8524767

    Modulators of ATP binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted
  5. US 8524910

    Pyridyl derivatives as CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted
  6. US 8524906

    Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted
  7. US 8524902

    [1,2,4]triazolo[4,3-f]pteridines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted
  8. US 8524720

    Substituted N-(pyrazol-5-yl)-pyrrolo[3,2-D]pyrimidin-4-amine useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted
  9. US 8519137

    Heteroaryl amides useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  10. US 8518953

    Aminopyrimidines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  11. US 8518938

    c-MET protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  12. US 8513282

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  13. US 8513414

    Processes and intermediates for producing azaindoles

    Vertex Pharmaceuticals Incorporated · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  14. US 8507534

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted
  15. US 8507524

    Modulators of ATP-binding cassette-transporters

    Vertex Pharmaceuticals Incorporated · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted
  16. US 8507687

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted
  17. US 8501446

    Azaindoles useful as inhibitors of JAK and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  18. US 8497295

    Spiroindoline modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted
  19. US 8492546

    Co-crystals and pharmaceutical compositions comprising the same

    Vertex Pharmaceuticals Incorporated · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted
  20. US 8492403

    Bicyclic derivatives as modulators of voltage gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted
  21. US 8492397

    Aminopyridine derivatives having Aurora A selective inhibitory action

    Vertex Pharmaceuticals Incorporated · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted
  22. US 8486989

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted
  23. US 8481578

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted
  24. US 8481538

    Heterocyclic inhibitors of c-Met and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted